NanoVibronix Secures $12M Commitment for PainShield with Distribution Agreement Extension

NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company specializing in surface acoustic wave (SAW) technology, has announced the renewal of its exclusive distribution agreement with Ultra Pain Products, Inc. (UPPI) for the distribution of the PainShield device. The five-year extension…

Read MoreNanoVibronix Secures $12M Commitment for PainShield with Distribution Agreement Extension

SamanTree Medical Reports 67% Reduction in Reoperation Rates for Breast-Conserving Surgery at 2024 SABCS

SamanTree Medical, a leader in oncologic surgical imaging innovation, announced promising results from the SHIELD study, to be presented at the 2024 San Antonio Breast Cancer Symposium (SABCS) on Dec. 12. The findings reveal that the Histolog® Scanner, a confocal…

Read MoreSamanTree Medical Reports 67% Reduction in Reoperation Rates for Breast-Conserving Surgery at 2024 SABCS

Syncell Announces $15 Million Series A to Boost Global Growth of Protein Purification and Spatial Proteomics Tech

Syncell, a leader in advanced subcellular protein purification and spatial proteomics analysis, has successfully closed a $15 million Series A funding round, bringing its total funding to $30 million. The capital will be used to drive the global commercialization and…

Read MoreSyncell Announces $15 Million Series A to Boost Global Growth of Protein Purification and Spatial Proteomics Tech

RevBio Gets FDA Approval to Expand Trial and CMS Reimbursement for Regenerative Bone Adhesive

RevBio, Inc. announced that it has received FDA approval to expand its ongoing clinical trial to use TETRANITE®, its bone adhesive biomaterial, for immediate cranial flap fixation. Additionally, the company has secured reimbursement coverage from the Centers for Medicare and…

Read MoreRevBio Gets FDA Approval to Expand Trial and CMS Reimbursement for Regenerative Bone Adhesive

Protaryx Medical Completes First-in-Human Study of Innovative Transseptal Puncture Technology

Protaryx Medical, a leader in medical device innovation, is proud to announce the successful completion of its First-in-Human (FIH) study for its groundbreaking transseptal puncture technology. The study, conducted on December 3, 2024, at Sanatorio Italiano de Asunción in Paraguay,…

Read MoreProtaryx Medical Completes First-in-Human Study of Innovative Transseptal Puncture Technology